BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:5th Annual Pharma Regulatory Summit 2022\n\n09th &amp\; 10th M
 arch 2022\, Virtual Conference (Time Zone – IST)\n\nJoin 5th Annual Pharm
 a Regulatory Summit 2022 to discuss multi-regional cooperation\, global h
 armonization and best practices related to India’s regulatory landscape. 
 Sessions will highlight regulatory approaches and good practices to ensur
 e certainty in India and strategic initiatives to improve collaboration a
 nd cooperation.\n\nDELEGATE REGISTRATION:\n\nE-mail - kavitha@virtueinsig
 ht.co.in or Call M: +91 9361957193 or +91 44 24762472\n\nPlease note that
  this is a PAID event and NOT A FREE event (no complimentary passes avail
 able). Any invite\, email or tickets issued mentioning it as a free pass 
 or free ticket to this event through any third party site will strictly n
 ot be accepted by the organizer.\n\n\nEarly Bird Discount Price&nbsp\;(Va
 lid Till 24th January 2022) –&nbsp\;(INR 7\,000 + GST (18%) per delegate)
 \nStandard Price&nbsp\;(Valid From 25th January 2022)&nbsp\; -&nbsp\;(INR
  9\,000 + GST (18%) per delegate)\n\nConference Sponsor\, Exhibition Stal
 l &amp\; Paid Speaker Slot - Please email your interest and queries to ka
 vitha@virtueinsight.co.in\n\nKEY SPEAKERS:\n\n\nRAJENDRA SANGHAVI\,&nbsp\
 ;Sr. Consulting Clinician &amp\; Chairman - Medical Committee\,&nbsp\;Ind
 ian Drug Manufacturers' Association (IDMA)\nRASHMI HEGDE\,&nbsp\;Executiv
 e Vice President Medical Affairs\,&nbsp\;GSK\nAMIT BHARGAVA\,&nbsp\;Vice-
  President and Head- Medical Services\,&nbsp\;Lupin\nPRASANNA BANGALE\,&n
 bsp\;Vice President and Head\, Global Regulatory Affairs\,&nbsp\;Alembic 
 Pharmaceuticals\nPRATIK SHAH\,&nbsp\;Vice President Medical Affairs\,&nbs
 p\;Bharat Serums and Vaccines\nNAVANEETHA SELVAN\,&nbsp\;Associate Vice P
 resident - Global Regulatory Affairs\,&nbsp\;Wockhardt\nSANJAY SHARMA\,&n
 bsp\;Vice President Technology Transfer\,&nbsp\;Lupin\nMANISH MISTRY\,&nb
 sp\;Medical Director\,&nbsp\;Novartis\nVAIBHAV CHOUDHARY\,&nbsp\;Joint Di
 rector\, Medical and Clinical Affairs\,&nbsp\;Fresenius Kabi Oncology\nRA
 JESH KHER\,&nbsp\;Director\, Business Operations\, Regulatory Medical Wri
 ting\,&nbsp\;Janssen\nANJU AGARWAL\,&nbsp\;Director Global Patient Safety
 \,&nbsp\;Advanz Pharma\nKRANTHI KIRAN PEBBILI\,&nbsp\;Director and Cluste
 r Head - Medical Affairs\,&nbsp\;Dr. Reddy’s Laboratories\nSHIRAZ KANDAWA
 LLA\,&nbsp\;Associate Director - Regulatory Affairs\,&nbsp\;Abbott\nAMEY 
 MANE\,&nbsp\;Director Medical Affairs\,&nbsp\;Dr. Reddy's Laboratories\nP
 RAVEEN KUMAR L\,&nbsp\;Director - Regulatory Affairs\,&nbsp\;Cipla\nYATEE
 N SHAH\,&nbsp\;Director - Regulatory Affairs &amp\; Quality\,&nbsp\;Johns
 on &amp\; Johnson\nKAVITA LAMROR\,&nbsp\;Director\, Real World Investigat
 or\, Digital Function\,&nbsp\;Sanofi\nVIPUL JAIN\,&nbsp\;Associate Direct
 or - SCM Integrated Business Planning\,&nbsp\;Cipla\nSHAHU INGOLE\,&nbsp\
 ;General Manager\, Head Medical Affairs\,&nbsp\;Wockhardt\nMANGALA KOTNIS
 \,&nbsp\;Head Regional Medical Affairs\,&nbsp\;Abbott\nVAIBHAV SALVI\,&nb
 sp\;Head – Medical Information\, Asia\,&nbsp\;Sanofi\nVICKRAM SRIVASTAVA\
 ,&nbsp\;Head of Planning - Global Supply Chain\,&nbsp\;Sun Pharma\nSADANA
 ND KULKARNI\,&nbsp\;Head-Medical\, Regulatory\, Vigilance\,&nbsp\;Quality
 \,&nbsp\;Fresenius Kabi\nVARSHA KHATRY\,&nbsp\;Head Medical and Scientifi
 c Affairs\, Quality and Regulatory\,&nbsp\;Roche\nGEETA SHANBHAG\,&nbsp\;
 Sr. General Manager – Pharmacovigilance &amp\; Medico-Regulatory Affairs\
 ,&nbsp\;Ipca Laboratories\nRAJENDRA JANI\,&nbsp\;Senior Subject Expert &a
 mp\; Advisor\, Clinical Research Consultant\nSANJIV DONWALKAR\,&nbsp\;Hea
 d - Operational Excellence\,&nbsp\;Novartis\nASHWANI PANDITA\,&nbsp\;Gene
 ral Manager - Clinical Quality Management &amp\; Training\,&nbsp\;Glenmar
 k\nRAVI GAWARE\,&nbsp\;Head of Clinical Operations\,&nbsp\;Novo Nordisk\n
 GANESH KADHE\,&nbsp\;Senior Leadership Team Member\, Scientific &amp\; Me
 dical Affairs\,&nbsp\;Abbott Nutrition\nAPARNA PRABHUNE\,&nbsp\;Asst Gene
 ral Manager Regulatory Affairs\,&nbsp\;Wockhardt\nSUDIPTO BASU\,&nbsp\;Se
 nior Manager - Demand Planning\,&nbsp\;Boehringer Ingelheim\nINDRANIL PUR
 KAIT\,&nbsp\;General Manager and Head Medical Affairs\,&nbsp\;Ipca Labora
 tories\nMANJIRI WARANG\,&nbsp\;Medical Writing - Clinical Development\,&n
 bsp\;Sun Pharma\n\nPlus many more joining soon\n\nKEY THEMES DISCUSSED:\n
 \n\nThe new normal for clinical development regulatory practices - Stayin
 g ahead of regulatory changes\nLessons to learn from Covid pandemic - Pot
 ential benefits and risks of regulatory flexibility Striking the balance\
 nPresent regulatory system for growth and effective production of medicin
 al products\nNew regulations in Pharmacovigilance and the way forward\nTh
 e role of technology within regulatory compliance\nPrioritizing patient s
 afety regulations\nDiscussing how to ensure operational performance in co
 mpliance with the aim of better regulation\nNew changes in Drug Supply Ch
 ain Security Act (DSCSA).\nRecent developments in GCP. How to succeed wit
 h this?\nUsage of mobile apps and medical devices in clinical trials – re
 gulatory challenges\nRWE implementation in clinical trials. What are the 
 challenges\, chances and curses?\nMoving to electronic package-level trac
 eability system – steps and barriers.\nRegulatory issues and maintaining 
 quality in medical writing.\nRegulatory environment for medical devices i
 n India as per 'New Medical Devices Rules'?\nRelationship between regulat
 ory and technology in medical devices? A better understanding.\nWhat are 
 the critical regulatory aspects for biotech companies? What should they l
 ook out for?\nBiosimilars market regulation\, what are the benefits and d
 rawbacks?\nUnderstanding the CGMPs under post pandemic. What changes will
  take place in priorities?\nEffective plans to maintain manufacturing and
  packing drug product methods under CGMPs?\nWays to improve the combinati
 on of quality\, safety and effectiveness in manufacturing.\nBe part of a 
 both (together and one) virtual networking opportunity\n\nWHO SHOULD ATTE
 ND AND WHO YOU’LL MEET:\n\nThis conference is specifically designed for P
 harma\, biotech\, CRO’s\, Government and Regulators\, Hospitals/Trial Sit
 es\, Technology &amp\; Solution Providers and medical device professional
 s responsible for:\n\n\nRegulatory Affairs\nRegulatory Writing/Medical Wr
 iting/Publishing/Information/Submissions\nDocument and e-Records Manageme
 nt\nBusiness Operations/Processing Labelling\nClinical Trials Management/
 Data\nClinical Data\nOutsourcing/Clinical Outsourcing/Vendor Management\n
 Product Development\nQuality Assurance/Quality Control\nPatient recruitme
 nt companies\nGovernment- Department of health\nNon-profit organizations/
  Association\, Consultants\n\nGet more from the event\, with a broader sc
 ope bringing the whole communications value chain together. Enjoy and mak
 e the best out of our dedicated networking time\, meet the leading intern
 ational vendors showcasing the products of tomorrow in the co-located exh
 ibition. Expand your knowledge of the latest business models and strategi
 es in the high-level conference\n
DTEND:20220310T170000
DTSTAMP:20260512T230905Z
DTSTART:20220309T090000
LOCATION:\,
SEQUENCE:0
SUMMARY:5th Annual Pharma Regulatory Summit 2022\n09th &amp\; 10th March 2
 022\, Virtual Conference (Time Zone – IST)\nJoin 5th Annual Pharma Regula
 tory Summi...
UID:d0e91425-bcaa-4fa7-a417-5b454cefd79e
END:VEVENT
END:VCALENDAR